All In Biotech

Free tool

FAERS Monitor: Zirgan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022211 or its brand name (Zirgan, Ganciclovir). Reports on generic versions are filed under their own applications.

Reports

10,361

Serious

9,837

95% of reports

Hospitalization

4,195

Death reported

3,155

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,720
  • drug ineffective1,484
  • cytomegalovirus infection1,208
  • drug resistance678
  • pyrexia607
  • product use in unapproved indication552
  • neutropenia548
  • pancytopenia525
  • diarrhoea450
  • cytomegalovirus viraemia434
  • pneumonia429
  • sepsis420
  • multiple organ dysfunction syndrome416
  • respiratory failure399
  • cytomegalovirus infection reactivation397

Reports by year received

View as table
YearReports
200473
200576
2006109
2007124
2008182
2009226
2010158
2011260
2012303
2013214
2014234
2015237
2016338
2017501
2018607
2019935
20201,023
2021938
2022858
2023850
2024848
2025799
2026466

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,798 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cytomegalovirus viraemiaSignal434219.3199.084,950
cytomegalovirus infection reactivationSignal397200.3181.071,504
cytomegalovirus infectionSignal1,208159.0150.5175,907
drug resistanceSignal67855.051.134,992
multiple organ dysfunction syndromeSignal41630.227.511,576
pancytopeniaSignal52519.217.79,000
respiratory failureSignal39911.210.13,674
neutropeniaSignal5488.27.63,472
sepsisSignal4207.77.02,433
product use in unapproved indicationSignal5524.54.21,529
off label useSignal1,7204.03.84,016
pyrexiaSignal6073.63.31,135
pneumoniaSignal4292.72.5461
drug ineffectiveSignal1,4842.32.21,144
diarrhoea4501.41.356

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.